Product NDC: | 0007-4407 |
Proprietary Name: | ARGATROBAN |
Non Proprietary Name: | argatroban |
Active Ingredient(s): | 100 mg/mL & nbsp; argatroban |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0007-4407 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020883 |
Marketing Category: | NDA |
Start Marketing Date: | 20001128 |
Package NDC: | 0007-4407-01 |
Package Description: | 1 VIAL in 1 CARTON (0007-4407-01) > 2.5 mL in 1 VIAL |
NDC Code | 0007-4407-01 |
Proprietary Name | ARGATROBAN |
Package Description | 1 VIAL in 1 CARTON (0007-4407-01) > 2.5 mL in 1 VIAL |
Product NDC | 0007-4407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | argatroban |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20001128 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ARGATROBAN |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |